Over the past 12 months, 6 insiders at REPLIGEN CORP filed 24 open-market SEC Form 4 transactions on RGEN: 1 purchase worth $202K and 23 sales worth $12.3M. Insiders have been net sellers over this period. The most recent filing was on Jul 16, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 16, 26 | Jason K GarlandCFO | SELL | 530 | $150.00 | $80K |
| Jun 25, 26 | Jason K GarlandCFO | SELL | 733 | $145.00 | $106K |
| Dec 17, 25 | Karen A DawesDirector | SELL | 275 | $161.00 | $44K |
| Nov 25, 25 | Olivier LoeillotChief Executive Officer | SELL | 7.0K | $170.00 | $1.2M |
| Nov 18, 25 | James BylundChief Operating Officer | SELL | 2.2K | $151.21 | $331K |
| Nov 13, 25 | Anthony HuntDirector | SELL | 5.7K | $157.11 | $896K |
| Nov 12, 25 | Anthony HuntDirector | SELL | 11.1K | $158.51 | $1.8M |
| Sep 10, 25 | Anthony HuntDirector | SELL | 14.9K | $122.23 | $1.8M |
| Aug 8, 25 | Martin D MadausDirector | BUY | 1.8K | $112.13 | $202K |
| May 15, 25 | Anthony HuntDirector | SELL | 17.6K | $127.00 | $2.2M |
| Mar 17, 25 | Anthony HuntDirector | SELL | 15.6K | $153.70 | $2.4M |
| Mar 17, 25 | Margaret PaxDirector | BUY | 250 | $150.69 | $38K |
| Nov 21, 24 | Anthony HuntDirector | SELL | 24.2K | $139.67 | $3.4M |
| Sep 10, 24 | Anthony HuntDirector | SELL | 10.7K | $146.67 | $1.6M |
| Aug 2, 24 | Ralf KuriyelSenior VP, R&D | SELL | 7.0K | $159.36 | $1.1M |
| Aug 1, 24 | Ralf KuriyelSenior VP, R&D | SELL | 4.5K | $165.67 | $740K |
| Jun 14, 24 | Nicolas BarthelemyDirector | BUY | 1.2K | $125.45 | $151K |
| Jun 14, 24 | Anthony HuntChief Executive Officer | BUY | 2.0K | $124.08 | $248K |
| Jun 14, 24 | Martin D MadausDirector | BUY | 915 | $125.46 | $114K |
| May 21, 24 | Anthony HuntChief Executive Officer | SELL | 4.3K | $171.03 | $711K |
| Mar 11, 24 | Ralf KuriyelSenior VP, R&D | SELL | 3.5K | $193.73 | $681K |
| Mar 8, 24 | Anthony HuntChief Executive Officer | SELL | 6.2K | $202.55 | $1.2M |
| Feb 27, 24 | Karen A DawesDirector | SELL | 1.0K | $193.35 | $193K |
| Feb 23, 24 | James BylundChief Operating Officer | SELL | 4.4K | $198.08 | $866K |
| Nov 10, 23 | Christine GebskiSee Remarks | SELL | 3.8K | $147.13 | $557K |
| Aug 29, 23 | Karen A DawesDirector | SELL | 850 | $171.38 | $146K |
| May 8, 23 | Martin D MadausDirector | BUY | 500 | $156.18 | $78K |
| May 5, 23 | Martin D MadausDirector | BUY | 500 | $159.19 | $80K |
| May 4, 23 | Martin D MadausDirector | BUY | 500 | $161.15 | $81K |
| Feb 16, 23 | Jon SnodgresChief Financial Officer | SELL | 5.6K | $200.00 | $1.1M |
| Nov 11, 22 | Anthony HuntChief Executive Officer | SELL | 25.0K | $200.00 | $5.0M |
| Sep 9, 22 | Karen A DawesDirector | SELL | 775 | $227.17 | $176K |
| Sep 8, 22 | Anthony HuntChief Executive Officer | SELL | 10.5K | $227.01 | $2.4M |
| Aug 16, 22 | Jon SnodgresChief Financial Officer | SELL | 4.3K | $253.16 | $1.1M |
| Aug 11, 22 | Ralf KuriyelSenior VP, R&D | SELL | 4.0K | $255.20 | $1.0M |
| Aug 4, 22 | Christine GebskiSee Remarks | SELL | 3.4K | $243.01 | $816K |
| Aug 3, 22 | James BylundChief Operating Officer | SELL | 2.0K | $240.40 | $481K |
| Aug 1, 22 | Jon SnodgresChief Financial Officer | SELL | 2.0K | $220.00 | $440K |
| Jul 21, 22 | Anthony HuntChief Executive Officer | SELL | 24.8K | $200.00 | $5.0M |
| May 25, 22 | Karen A DawesDirector | SELL | 7.7K | $152.84 | $1.2M |
| Mar 16, 22 | Manner Carrie EglintonDirector | BUY | 625 | $175.02 | $109K |
| Mar 1, 22 | Thomas F Ryan JrDirector | SELL | 1.0K | $198.48 | $198K |
| Nov 18, 21 | Anthony HuntChief Executive Officer | SELL | 6.0K | $281.40 | $1.7M |
| Nov 10, 21 | Karen A DawesDirector | SELL | 1.1K | $271.28 | $295K |
| Nov 4, 21 | Thomas F Ryan JrDirector | SELL | 1.0K | $288.00 | $288K |
| Nov 2, 21 | Karen A DawesDirector | SELL | 700 | $306.49 | $214K |
| Nov 2, 21 | Thomas F Ryan JrDirector | SELL | 1.3K | $302.00 | $388K |
| Oct 29, 21 | Nicolas BarthelemyDirector | SELL | 1.3K | $288.20 | $370K |
| Sep 14, 21 | Karen A DawesDirector | SELL | 108 | $295.82 | $32K |
| Sep 9, 21 | Anthony HuntChief Executive Officer | SELL | 14.8K | $296.58 | $4.4M |
Over the past 12 months, insiders at REPLIGEN CORP filed 1 open-market purchase worth $202K and 23 sales worth $12.3M on RGEN, which makes them net sellers over the period. The most recent Form 4 was filed on Jul 16, 26.
The largest recent open-market RGEN insider purchase in our data was $248K by Anthony Hunt, Chief Executive Officer, filed on Jun 14, 24.
6 different insiders at REPLIGEN CORP filed open-market SEC Form 4 transactions on RGEN over the last 12 months.
InsiderTape plots every RGEN insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every REPLIGEN CORP insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →